Today: 20 July 2026
Browse Category

NYSE:DGX 29 July 2025 - 4 December 2025

Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health, Inc. is in the spotlight today after officially rolling out its new “Labs” diagnostic platform in partnership with Quest Diagnostics, even as the stock trades sharply lower and Wall Street sentiment turns more cautious. The telehealth company is trying to push deeper into preventive, data-led healthcare at the same time investors are digesting rich valuations, insider selling and tighter 2025 guidance. Investing.com+4Hims Investors+4Investing.com Australia+4
14 November 2025
AI Just Diagnosed You—Now What? The Rise of Superhuman Doctors Made of Code

AI Just Diagnosed You—Now What? The Rise of Superhuman Doctors Made of Code

A boy in the U.S. suffered chronic pain for three years. He saw 17 different doctors and still had no diagnosis. In desperation, his mother typed his symptoms into an AI chatbot. The reply came in seconds: spina bifida occulta – a rare spinal condition. A specialist later confirmed this was the correct diagnosis nihrecord.nih.gov. It sounds like science fiction: an artificial intelligence succeeding where human experts failed. But this real-world case is a striking sign of how AI is beginning to transform medical diagnostics. From reading X-rays and CT scans to spotting elusive rare diseases, these “superhuman doctors made of code” are rapidly becoming trusted partners in healthcare.
Go toTop